Tassitron-S 1.5 Injection
Marketer
Asiatic Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Tassitron-S 1.5 Injection
Tassitron-S 1.5 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation and infection spread. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Escalating side effects necessitate immediate medical consultation. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require urgent medical attention. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and ample hydration support recovery. Your doctor might order tests to monitor the medicine's effects.
Uses of Tassitron-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Tassitron-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tassitron-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Tassitron-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Tassitron-S 1.5 Injection works:
Ceftriaxone and Sulbactam, the components of Tassitron-S 1.5 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, inhibits bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Tassitron-S 1.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The administration of Tassitron-S 1.5 Injection during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Tassitron-S 1.5 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Tassitron-S 1.5 Injection may induce drowsiness, blurred vision, or dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tassitron-S 1.5 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Tassitron-S 1.5 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Tassitron-S 1.5 Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Tassitron-S 1.5 Injection :
Omit a dose of Tassitron-S 1.5 Injection? Seek your physician's advice.
Facts to Know About Tassitron-S 1.5 Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Antimicrobial agents |
3,018 People bought this recently